Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation?
Saved in:
| Title: | Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation? |
|---|---|
| Authors: | Yiong CS; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, 117544, Singapore., Lin TP; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, 117544, Singapore., Lim VY; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Toh TB; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Yang VS; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. yangswv@imcb.a-star.edu.sg.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore. yangswv@imcb.a-star.edu.sg.; Duke-NUS Medical School, Oncology Academic Clinical Program, Singapore, 169857, Singapore. yangswv@imcb.a-star.edu.sg. |
| Source: | Biomarker research [Biomark Res] 2023 Aug 23; Vol. 11 (1), pp. 75. Date of Electronic Publication: 2023 Aug 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37612756 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yiong+CS%22">Yiong CS</searchLink>; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, 117544, Singapore.<br /><searchLink fieldCode="AU" term="%22Lin+TP%22">Lin TP</searchLink>; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, 117544, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+VY%22">Lim VY</searchLink>; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.<br /><searchLink fieldCode="AU" term="%22Toh+TB%22">Toh TB</searchLink>; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Yang+VS%22">Yang VS</searchLink>; Translational Precision Oncology Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. yangswv@imcb.a-star.edu.sg.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore. yangswv@imcb.a-star.edu.sg.; Duke-NUS Medical School, Oncology Academic Clinical Program, Singapore, 169857, Singapore. yangswv@imcb.a-star.edu.sg. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101607860%22">Biomarker research</searchLink> [Biomark Res] 2023 Aug 23; Vol. 11 (1), pp. 75. <i>Date of Electronic Publication: </i>2023 Aug 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101607860 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2050-7771 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220507771%22">20507771 </searchLink><i>NLM ISO Abbreviation: </i>Biomark Res <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37612756 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40364-023-00513-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 75 Titles: – TitleFull: Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yiong CS – PersonEntity: Name: NameFull: Lin TP – PersonEntity: Name: NameFull: Lim VY – PersonEntity: Name: NameFull: Toh TB – PersonEntity: Name: NameFull: Yang VS IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 08 Text: 2023 Aug 23 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2050-7771 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Biomarker research Type: main |
| ResultId | 1 |
